Cellular Biomedicine (CBMG) Stock Price, Forecast & Analysis
USA - NASDAQ:CBMG -
CBMG Key Statistics, Chart & Performance
The current stock price of CBMG is 19.75 null. In the past month the price increased by 9.72%. In the past year, price increased by 18.41%.
CBMG Latest News, Press Relases and Analysis
About CBMG
Company Profile
Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments utilizing proprietary cell technologies for the treatment of a range of cancers; joint disease and central nervous system diseases. Cellular Biomedicine Group Inc. is headquartered in Palo Alto, California.
Company Info
Cellular Biomedicine
1345 AVENUE OF AMERICAS 15TH FLOOR
NEW YORK NY 10105
CEO: Bizuo (Tony) Liu
Phone: 347-905-5663
Cellular Biomedicine / CBMG FAQ
What does Cellular Biomedicine do?
Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments utilizing proprietary cell technologies for the treatment of a range of cancers; joint disease and central nervous system diseases. Cellular Biomedicine Group Inc. is headquartered in Palo Alto, California.
What is the current price of CBMG stock?
The current stock price of CBMG is 19.75 null.
What is the dividend status of Cellular Biomedicine?
CBMG does not pay a dividend.
What is the ChartMill rating of Cellular Biomedicine stock?
CBMG has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the Price/Earnings (PE) ratio of Cellular Biomedicine (CBMG)?
Cellular Biomedicine (CBMG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.82).
CBMG Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CBMG. When comparing the yearly performance of all stocks, CBMG turns out to be only a medium performer in the overall market: it outperformed 49.81% of all stocks.
CBMG Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CBMG. Both the profitability and financial health of CBMG have multiple concerns.
CBMG Financial Highlights
Over the last trailing twelve months CBMG reported a non-GAAP Earnings per Share(EPS) of -2.82. The EPS decreased by -17.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -16967.89% | ||
| ROA | -58.88% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |